 Solution

Objective and rationale. Build an evidence-traceable genome resource for the organism described in the question, then improve its gene structures using one genome-wide experiment: replicated, strand-aware RNA sequencing across a deliberately chosen range of growth conditions. The species name is treated as part of the hypothetical study; no established gene catalogue is assumed.

Poor annotation limits both discovery and interpretation. Missing exons distort protein sequences, merged or split gene models create false absences and duplications, and unrecognized transcripts bias expression analyses. Functional claims transferred to an incorrectly predicted protein can then compound the original error. Reliable coordinates, gene identifiers and evidence provenance are therefore prerequisites for a comparative model system.

Resource construction. Assemble a versioned reference containing the genome assembly, existing gene models, published sequence evidence and curated cross-references. Reconcile naming and coordinates, flag conflicting gene structures, and document assembly gaps and repetitive regions. Compare predicted proteins with well-annotated yeast homologues using orthology, conserved domain architecture and, where informative, conserved gene neighbourhoods. Sequence similarity is evidence for a relationship; it is not sufficient to give every paralogue its best hit's exact function.

Genome-wide experiment. Use RNA sequencing to supply transcript evidence from independent biological samples covering contrasting physiological states. Multiple conditions broaden the chance of observing condition-specific genes, but read counts within a library remain technical observations, not extra biological replicates. Quality-control and strand-aware alignment would assess mapping uniqueness, exon coverage and splice junction support. Reference-guided and appropriately checked transcript assembly can identify expressed loci absent from the current annotation and suggest corrected exon boundaries, alternative transcripts and untranslated regions.

Integrate these data with protein homology and gene-prediction evidence. A proposed exon should have coherent splice support and coding plausibility; an isolated ambiguous read is insufficient. Keep alternative models and confidence levels when repeat structure or incomplete coverage prevents a unique assignment. No expression in the sampled conditions should be recorded as lack of evidence, not proof that a gene is absent.

Validation and functional annotation. Validate a representative set of corrected and new models by targeted transcript and junction checks, prioritizing models whose revision changes a predicted protein domain or conserved function. Retain known positive controls and distinguish biological alternatives from assembly or mapping errors. Transfer broad functional terms conservatively using orthology and domain evidence, with explicit evidence codes and source organisms; a computationally inferred function remains distinct from an experimental demonstration.

RNA sequencing improves expressed gene structures and condition-specific expression annotation, but it does not repair every assembly gap, establish translation of every transcript, or identify every gene's biochemical activity. Those limitations should remain visible in the resource. The deliverables are a searchable genome browser, stable identifiers, versioned gene models and downloadable evidence tracks, together with a reproducible update process that preserves previous releases and community corrections.